Live feed
Filing
SC 13G/A
SC 13G/A0001085146-22-001034·CASI Pharmaceuticals, Inc (DE)
Schedule 13G ownership disclosure
CASI PHARMACEUTICALS INC
Security class unavailable · CUSIP: 14757U109
Event date: 2021-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 0
- Percent of class
- 0.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001085146-22-001034
- Form type
- SC 13G/A
- Filer
- CASI Pharmaceuticals, Inc (DE)
- CIK
- CIK 895051
- Filed
- Feb 14, 2022
- Reporting period
- Dec 31, 2021
- Description
- Schedule 13G beneficial ownership